截至2022年6月6日,印度已记录到25,782例活跃期病例和524,701例死于19型冠状病毒病(COVID-19)。在大流行的耀斑中,喀拉拉邦卷入了多种新出现的传染病的愤怒之中。印度,13亿人的家园,最近在2021年5月面临着毁灭性的第二波COVID-19,伴随着长期缺药的骚动,氧气供应,呼吸机,此外,受到二次感染和慢性健康疾病的挑战。喀拉拉邦,仅COVID-19病例数就占50%,此外,最近同时爆发的寨卡病毒病(ZVD),尼帕病毒病(NiVD)和黑热病(黑热病)分别于2021年7月8日,9月5日和8日。这些高度传染性疾病的普遍性和高病死率,再加上感染后的后遗症,压倒了已经脆弱的医疗系统。因此,这些致命的传染病以及预期的第三波COVID-19在印度南部及其周边地区构成了严重的公共卫生威胁。通过这篇叙述性评论,我们的目标是讨论寨卡病毒交叉爆发的挑战,尼帕,Kala-azar礼物,在国家,在COVID-19全球大流行的情况下,并提供建议,以帮助缓解这种情况。COVID-19与其他传染病的共通性,呼吁对疾病爆发进行充分的监测和监测。为了避免像大流行这样最糟糕的情况,卫生部,印度的公共和私人卫生利益相关者应加强公共医疗保健提供系统和快速医疗设施的提供,以控制疫情期间的死亡率和发病率。
As of 6 June 2022, a sum 25,782 of active cases and 524,701 deaths due to Coronavirus disease-19 (COVID-19) have been recorded in India. Stewing in the flares of the pandemic, Kerala is entwined in the wrath of multiple emerging infectious diseases. India, a home to 1.3 billion people, recently faced a devastating second wave of COVID-19 during May of 2021, with a ruckus of chronic shortage of medicine, oxygen supplies, ventilators, besides, being challenged by secondary infections and chronic health ailments. The state of Kerala, alone contributes to 50% COVID-19 caseload, besides, recent simultaneous outbreaks of Zika Virus Disease (ZVD), Nipah Virus Disease (NiVD) and Kala-azar (black fever) on July 8, September 5 and 8, 2021 respectively. Syndemicity and a high case fatality rates of these highly contagious diseases coupled with post infection sequelae, overwhelm the already fragile healthcare system. Thus, these lethal infectious diseases along with an anticipated third wave of COVID-19 pose a serious public health threat in and around South India. With this narrative review, we aim to discuss the challenges that the emergence of intersecting outbreaks of Zika, Nipah, Kala-azar presents with, in the nation, amidst the global pandemic of COVID-19 and provide recommendations so as to help alleviate the situation. The syndemicity of COVID-19 with other infectious diseases, calls for adequate surveillance and monitoring of diseases\' outbreaks. To avoid the worst situations like pandemic, the health ministry, public and private health stakeholders in India should strengthen the public healthcare delivery system and providence of quick medical facilities to control the rate of mortality and morbidity during outbreaks.